CTOs on the Move


 
Kronus is a Boise, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.kronus.com
  • 12554 W Bridger St Ste 108
    Boise, ID USA 83713
  • Phone: 208.377.4800

Executives

Name Title Contact Details

Similar Companies

PlayMaker Health

PlayMaker Health`s post-acute software transforms provider claims into actionable business intelligence. Integrating within existing industry workflows, the platform, and mobile-first CRM unify market and sales performance data, delivering the actionable analytics and business intelligence post-acute providers need to accelerate growth and expand competitive market share.

Tennessee Heart and Vascular

Tennessee Heart and Vascular is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Hendersonville, TN. To find more information about Tennessee Heart and Vascular, please visit www.tennheart.com

Convenience Kits Intl.

Convenience Kits Intl. is a Lynbrook, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Access Plans USA, Inc.

Access Plans USA, Inc. (Access Plans) develops and distributes health care programs for individuals, and employer groups. Its products and programs include health insurance plans and non-insurance health care discount programs.

RaNA Therapeutics

RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.